MediPharm Labs Corp. (OTCMKTS:MEDIF – Get Free Report) was the target of a large drop in short interest during the month of July. As of July 31st, there was short interest totaling 997 shares, a drop of 92.7% from the July 15th total of 13,638 shares. Based on an average daily volume of 168,076 shares, the short-interest ratio is currently 0.0 days.
MediPharm Labs Stock Performance
OTCMKTS:MEDIF opened at $0.05 on Wednesday. MediPharm Labs has a 12-month low of $0.04 and a 12-month high of $0.08. The stock’s 50 day moving average price is $0.05 and its two-hundred day moving average price is $0.05.
About MediPharm Labs
MediPharm Labs Corporation is a Canada-based company focused on the extraction, formulation and manufacturing of pharmaceutical-grade cannabis products. Through proprietary processes and a GMP-compliant facility in Mississauga, Ontario, the company produces high-purity distillates, isolates and advanced formulations tailored to both medical and adult-use markets.
The company’s core offerings include THC and CBD distillates, crystalline isolates, softgel capsules, oral thin films and sterile injectable products.
Featured Stories
- Five stocks we like better than MediPharm Labs
- Fastly’s Q2 Rally Shows Investors Are Buying the Edge AI Turnaround
- Paramount’s 30-Film Promise Puts AMC Back in the Box Office Conversation
- DraftKings’ Predictions Push Could Be the Bet That Matters Most
- Atlassian Just Pulled Off the Software Comeback Wall Street Wanted
Receive News & Ratings for MediPharm Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MediPharm Labs and related companies with MarketBeat.com's FREE daily email newsletter.
